<?xml version="1.0" encoding="UTF-8"?>
<p>To overcome these remaining challenges, the regulatory compliance of facilities, materials, and procedures for production of NoV VLPs under current Good Manufacture Practice (cGMP) has to be addressed first. Our group has led the effort in this area and established the first cGMP-compliant bioprocessing facility in academia for the production of NoV VLPs in plants [
 <xref ref-type="bibr" rid="CR0008126">126</xref>].
</p>
